Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would consider new talks with insurers concerning the listing selling prices of Wegovy and copyright should they pledge to keep the medicines on their formularies. This strategy aligns https://kethek.com/